Marco Soriani is a highly accomplished R&D and CMC Project Director with an impressive background in vaccine discovery, infectious diseases, microbiology, cellular biology, biochemistry, molecular biology, and immunology. With a Doctor of Philosophy in Biochemistry from the Universität Zürich and a Laurea in Biologia, Biochimica e biologia molecolare from Sapienza Università di Roma, he has an excellent publication record and solid international scientific experience.

He currently serves as a Project Director at REITHERA S.R.L., where he applies his deep expertise in vaccine technologies to develop innovative vaccines. In his previous roles, he served as a Manager at REITHERA S.R.L, R&D Consultant at Fondazione Toscana Life Sciences, Director at IRBM, Project Leader at GSK, Unit Head at Novartis Vaccines, Laboratory Head at Chiron Corporation, Medical Research Council Fellow at the University of Bristol, Senior Research Associate at the University of Bristol, and Post-doctoral Fellow at Swiss Institute for Experimental Cancer Research.

Marco's key strengths include management, networking, innovation, problem-solving, and creating scientific networks to access innovative technologies. He has also managed and coordinated several grant applications and European projects. Marco's expertise in vaccine technologies ranges from recombinant to genetic vaccines.